Comparison of intraperitoneal continuous infusion of floxuridine and bolus administration in a peritoneal gastric cancer xenograft model

Cancer Chemotherapy and Pharmacology

Volumn 53, Issue 5, 2004, Pages 415-422

  Inoue, Kentaro ^a,c   Onishi, Hiraku ^b   Kato, Yoshinori ^b   Michiura, Taku ^a   Nakai, Koji ^a   Sato, Mutsuya ^a   Yamamichi, Keigo ^a   Machida, Yoshiharu ^b   Nakane, Yasushi ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b HOSHI UNIVERSITY   (Japan)

^c NONE   (Japan)

Author keywords

Adjuvant chemotherapy; Drug delivery system; FUDR; Microsphere; PLGA

Indexed keywords

FLOXURIDINE; GLYCOLIC ACID; MICROSPHERE; POLYGLACTIN; TETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASSAY; BOLUS INJECTION; CANCER INHIBITION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG INFUSION; DRUG POTENCY; DRUG RELEASE; ENCAPSULATION; EXPOSURE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MAXIMUM TOLERATED DOSE; MODEL; NONHUMAN; PERITONEUM CANCER; PERITONEUM METASTASIS; PRIORITY JOURNAL; RAT; STOMACH CANCER; TUMOR XENOGRAFT;

ANIMALS; FLOXURIDINE; HUMANS; INJECTIONS, INTRAPERITONEAL; LACTIC ACID; MALE; MAXIMUM TOLERATED DOSE; MICE; MICE, INBRED BALB C; MICROSPHERES; NEOPLASM TRANSPLANTATION; POLYGLYCOLIC ACID; POLYMERS; RATS; RATS, INBRED F344; STOMACH NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS;

EID: 2142642244     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-003-0748-z     Document Type: Article

References (29)

1. Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37 [Suppl 8]:S4
2. Shimada K, Ajani JA (1999) Adjuvant therapy for gastric carcinoma patients in the past 15 years: a review of western and oriental trials. Cancer 86:1657
3. Earle CC, Maroun JA (1999) Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. Eur J Cancer 35:1059
4. Mari E, Floriani I, Tinazzi A, Buda A, Belfiglio M, Valentini M, Cascinu S, Barni S, Labianca R, Torri V (2000) Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente). Ann Oncol 11:837
5. Janunger KG, Hafstrom L, Nygren P, Glimelius B (2001) A systematic overview of chemotherapy effects in gastric cancer. Acta Oncol 40:309
6. Panzini I, Gianni L, Fattori PP, Tassinari D, Imola M, Fabbri P, Arcangeli V, Drudi G, Canuti D, Fochessati F, Ravaioli A (2002) Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses. Tumori 88:21
7. Yoo CH, Noh SH, Shin DW, Choi SH, Min JS (2000) Recurrence following curative resection for gastric carcinoma. Br J Surg 87:236
8. Maehara Y, Hasuda S, Koga T, Tokunaga E, Kakeji Y, Sugimachi K (2000) Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg 87:353
9. Markman M (2001) Intraperitoneal drug delivery of antineoplastics. Drugs 61:1057
10. Muggia FM, Chan KK, Russell C, Colombo N, Speyer JL, Sehgal K, Jeffers S, Sorich J, Leichman L, Beller U (1991) Phase I and pharmacologic evaluation of intraperitoneal 5-fluoro-2′-deoxyuridine. Cancer Chemother Pharmacol 28:241
11. Leichman L, Silberman H, Leichman CG, Spears CP, Ray M, Muggia FM, Kiyabu M, Radin R, Laine L, Stain S (1992) Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: a University of Southern California pilot program. J Clin Oncol 10:1933
12. Kelsen DP, Saltz L, Cohen AM, Yao TJ, Enker W, Tong W, Tao Y, Bertino JR (1994) A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer. Cancer 74:2224
13. Muggia FM, Liu PY, Alberts DS, Wallace DL, O'Toole RV, Terada KY, Franklin EW, Herrer GW, Goldberg DA, Hannigan EV (1996) Intraperitoneal mitoxantrone or floxuridine: effects on time-to-failure and survival in patients with minimal residual ovarian cancer after second-look laparotomy - a randomized phase II study by the Southwest Oncology Group. Gynecol Oncol 61:395
14. Crookes P, Leichman CG, Leichman L, Tan M, Laine L, Stain S, Baranda J, Casagrande Y, Groshen S, Silberman H (1997) Systemic chemotherapy for gastric carcinoma followed by postoperative intraperitoneal therapy: a final report. Cancer 79:1767
15. Culliford AT 4th, Brooks AD, Sharma S, Saltz LB, Schwartz GK, O'Reilly EM, Ilson DH, Kemeny NE, Kelsen DP, Guillem JG, Wong WD, Cohen AM, Paty PB (2001) Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer. Ann Surg Oncol 8:787
16. Okada H, Toguchi H (1995) Biodegradable microspheres in drug delivery. Crit Rev Ther Drug Carrier Syst 12:1
17. Smith-Rogers JA, Tong WP, Duafala ME, Markman M, Bertino JR (1991) High-performance liquid chromatographic method for the simultaneous measurement of floxuridine and fluorouracil in human body fluids. J Chromatogr 566:147
18. Poorter RL, Bakker PJ, Veenhof CH (1998) Continuous infusion of chemotherapy: focus on 5-fluorouracil and fluorodeoxyuridine. Pharm World Sci 20:45
19. Makhija S, Leitao M, Sabbatini P, Bellin N, Almadrones L, Leon L, Spriggs DR, Barakat R (2001) Complications associated with intraperitoneal chemotherapy catheters. Gynecol Oncol 81:77
20. Markman M (1991) Intraperitoneal chemotherapy. Semin Oncol 18:248
21. Link KH, Aigner KR, Peschau K, Warthona M, Schwemmle K, Danenberg PV (1988) Concentration and time dependence of the toxicity of fluorinated pyrimidines to HT 29 colorectal carcinoma cells. Cancer Chemother Pharmacol 22:58
22. Sullivan RD, Miller E (1965) The clinical effects of prolonged intravenous infusion of 5-fluoro-2′-deoxyuridine. Cancer Res 25:1025
23. Lokich JJ, Sonneborn H, Paul S, Zipoli T (1983) Phase I study of continuous venous infusion of floxuridine (5-FUDR) chemotherapy. Cancer Treat Rep 67:791
24. Moertel CG, Reitemeier RJ, Hahn RG (1967) A controlled comparison of 5-fluoro-2′-deoxyuridine therapy administered by rapid intravenous injection and by continuous intravenous infusion. Cancer Res 27:549
25. Meta-analysis Group In Cancer (1998) Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J Clin Oncol 16:301
26. Ensminger WD, Rosowsky A, Raso V, Levin DC, Glode M, Come S, Steele G, Frei E (1978) A clinical-pharmacological evaluation of hepatic arterial infusions of 5-fluoro-2′-deoxyuridine and 5-fluorouracil. Cancer Res 38:3784
27. Meta-Analysis Group In Cancer (1996) Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer. J Natl Cancer Inst 88:252
28. Kemeny N, Huang Y, Cohen AM, Shi W, Conti JA, Brennan MF, Bertino JR, Turnbull AD, Sullivan D, Stockman J, Blumgart LH, Fong Y (1999) Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341:2039
29. Kemeny MM, Adak S, Gray B, Macdonald JS, Smith T, Lipsitz S, Sigurdson ER, O'Dwyer PJ, Benson AB (2002) Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy - an intergroup study. J Clin Oncol 20:1499